Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion type Assertion NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_head.
- NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion wasGeneratedBy ECO_0000203 NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_provenance.
- NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion wasDerivedFrom befree-20140225 NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_provenance.
- NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion SIO_000772 18044827 NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_provenance.
- NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion evidence source_evidence_literature NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_provenance.
- NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_assertion description "[Furthermore, we identified three surrogate markers of ECM1 tumours: MARCO, PUNC, and SPARC, whose expression levels were associated with breast cancer survival and risk of recurrence.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386950.RACHoK65RMevNDN9k8d31Yx8bMXNsCGYoD7_ZedW1FVpM130_provenance.